Toshiki Otoda Selected Research

Toshiki Otoda Research Topics

Disease

6	Type 2 Diabetes Mellitus (MODY) 11/2023 - 01/2012
4	Insulin Resistance 12/2021 - 01/2012
3	Diabetic Nephropathies (Diabetic Nephropathy) 11/2023 - 01/2014
2	Hypoglycemia (Reactive Hypoglycemia) 02/2024 - 01/2016
2	Albuminuria 10/2023 - 12/2021
2	Inflammation (Inflammations) 10/2023 - 01/2012
2	Fibrosis (Cirrhosis) 08/2023 - 01/2012
2	Non-alcoholic Fatty Liver Disease 08/2023 - 01/2012
1	Proteinuria 10/2023
1	Coma (Comas) 01/2023
1	T-Cell Leukemia (Leukemia, T Cell) 01/2023
1	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 01/2023
1	Diabetes Mellitus 12/2021
1	Gestational Diabetes (Gestational Diabetes Mellitus) 12/2021
1	Hyperglycemia 03/2015
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2014
1	Kidney Diseases (Kidney Disease) 01/2014
1	Obesity 03/2013
1	Osteoporosis 03/2013
1	Hepatocellular Carcinoma (Hepatoma) 03/2013
1	Postmenopausal Osteoporosis 03/2013
1	Venous Thromboembolism 03/2013
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2009
1	Pancreatitis 01/2009

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 10/2023 - 12/2021
3	Glucose (Dextrose)FDA LinkGeneric 10/2023 - 01/2012
3	Proteins (Proteins, Gene)FDA Link 01/2023 - 03/2013
3	Sitagliptin Phosphate (Januvia)FDA Link 01/2016 - 03/2015
2	Fatty Acid-Binding ProteinsIBA 11/2023 - 12/2021
2	Heparin Cofactor IIIBA 08/2023 - 12/2021
2	Thrombin FDA Link 08/2023 - 12/2021
1	Insulin (Novolin)FDA Link 02/2024
1	Insulin SecretagoguesIBA 02/2024
1	Advanced Glycation End ProductsIBA 11/2023
1	Syntex adjuvant formulationIBA 11/2023
1	AndrogensIBA 11/2023
1	Dehydroepiandrosterone SulfateIBA 11/2023
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 10/2023
1	ReninIBA 10/2023
1	SodiumIBA 10/2023
1	AngiotensinsIBA 10/2023
1	Sodium-Glucose Transporter 2 InhibitorsIBA 10/2023
1	Proteinase-Activated ReceptorsIBA 08/2023
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 08/2023
1	DNA (Deoxyribonucleic Acid)IBA 01/2023
1	CreatinineIBA 12/2021
1	AlbuminsIBA 12/2021
1	Estradiol (Delestrogen)FDA LinkGeneric 12/2021
1	Blood Glucose (Blood Sugar)IBA 12/2021
1	Hemoglobins (Hemoglobin)IBA 01/2016
1	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2016
1	voglibose (Basen)IBA 01/2016
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2016
1	Liraglutide FDA Link 03/2015
1	VildagliptinIBA 03/2015
1	ATP dependent 26S protease (26S proteasome)IBA 03/2013
1	Phosphotransferases (Kinase)IBA 03/2013
1	Plasminogen Activators (Plasminogen Activator)IBA 03/2013
1	Plasminogen Activator Inhibitor 1IBA 03/2013
1	Raloxifene Hydrochloride (Evista)FDA Link 03/2013
1	Proteasome Endopeptidase Complex (Proteasome)IBA 03/2013
1	Bortezomib (Velcade)FDA Link 03/2013
1	Triglycerides (Triacylglycerol)IBA 01/2012
1	Metformin (Glucophage)FDA LinkGeneric 01/2012
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2012
1	AntigensIBA 01/2009
1	Pancreatic Elastase (Elastase)IBA 01/2009

Therapy/Procedure

2	Therapeutics 01/2023 - 03/2015
2	Glycemic Control 01/2016 - 03/2015
1	Aftercare (After-Treatment) 10/2023
1	Drug Therapy (Chemotherapy) 01/2023
1	Diet Therapy (Therapy, Diet) 01/2016
1	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2014
1	Protein-Restricted Diet (Diet, Protein Restricted) 01/2014